🔎 Trials Near Me

Akèy › Ensifizyans kadyak › Ohio › Cleveland

Etid klinik pou Ensifizyans kadyak nan Cleveland, OH

33 etid pou Ensifizyans kadyak ap chèche patisipan nan sit nan ak bò kote Cleveland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

Ap rekriteFaz 3
  • VA Northeast Ohio Healthcare System, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06935370

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

Ap rekriteFaz 3
  • University Hospitals Cleveland Medical Center, Cleveland
  • Cleveland Clinic, Cleveland
Laj 18 a 85 · Tout sèks · Mizajou Sep 24, 2026 · NCT06736574

Alleviant ALLAY-HFrEF Study

Ap rekrite
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT06812533

The WiSE®-UP Study (The WiSE System Utilization & Performance Study)

Ap rekriteEtid obsèvasyon
  • Cleveland Clinic Foundation, Cleveland
Laj 22 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT07098858

Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation

Ap rekriteEtid obsèvasyon
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT07436299

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

Ap rekrite
  • Cleveland Clinic, Cleveland
Laj 18 a 100 · Tout sèks · Mizajou Sep 9, 2026 · NCT06310031

Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

Ap rekriteFaz 2/3
  • Cleveland Clinic-Cleveland Clinic Chidren's ( Site 0022), Cleveland
29 Days – 17 Years · Tout sèks · Mizajou Aug 28, 2026 · NCT05714085

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Ap rekriteEtid obsèvasyon
  • Cleveland, Cleveland
Tout laj · Tout sèks · Mizajou Aug 20, 2026 · NCT00271180

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

Ap rekriteFaz 3
  • Tenax Investigational Site, Cleveland
Laj 18 a 85 · Tout sèks · Mizajou Aug 19, 2026 · NCT07288398

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Ap rekriteFaz 3
  • Louis Stokes Clvlnd VA Med Ctr, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07567001

Alleviant ALLAY-HF Study

Ap rekrite
  • Cleveland Clinic, Cleveland
Laj 40 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT05685303

Assessment of CCM in HF With Higher Ejection Fraction

Ap rekrite
  • Cleveland Clinic Foundation, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT05064709

Longitudinal Validation of CIRC Technologies

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT07081711

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

Ap rekrite
  • University Hospital (Cleveland), Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT05934487

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

Ap rekrite
  • The Cleveland Clinic Foundation, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT06526195

Early Assessment and Initiation of GuideLine-Directed Evidence-Based Management-HF

Ap rekriteEtid obsèvasyon
  • Cleveland Clinic, Cleveland
Laj 40 ak plis · Tout sèks · Mizajou May 8, 2026 · NCT06849752

CV Imaging of Metabolic Interventions

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Cardiovascular Innovation Research Center, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou May 8, 2026 · NCT05650307

Development of CIRC Technologies

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Cardiovascular Innovation Research Center, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou May 8, 2026 · NCT05654272

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

Ap rekrite
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT03142152

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

Ap rekriteFaz 3
  • Cleveland Clinic Foundation, Cleveland
Laj 18 a 75 · Tout sèks · Mizajou Mar 24, 2026 · NCT06217302

A SkeleTal Muscle Recovery Intervention With Dietary Protein in Heart Failure

Ap rekrite
  • Cleveland Clinic, Cleveland
Laj 18 a 100 · Tout sèks · Mizajou Nov 25, 2025 · NCT05627440

Fluid Guided Heart Failure Treatment at the Cleveland Clinic

Ap rekrite
  • The Cleveland Clinic, Cleveland
Laj 21 ak plis · Tout sèks · Mizajou Nov 12, 2025 · NCT07205120

Left vs Left Randomized Clinical Trial

Ap rekrite
  • The MetroHealth System, Cleveland
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2025 · NCT05650658

Home-Based Exercise Program Using Mobile Technology After Left Ventricular Assist Device Implantation

Ap rekrite
  • Cleveland Clinic Foundation, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 26, 2025 · NCT06291922

AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM

Ap rekriteEtid obsèvasyon
  • Cleveland Clinic, Cleveland
Laj 22 ak plis · Tout sèks · Mizajou Mar 26, 2025 · NCT06378632

Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC

Ap rekriteFaz 1
  • Cleveland Clinic, Cleveland
Laj 18 a 65 · Tout sèks · Mizajou Feb 6, 2025 · NCT06228924

Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"

Ap rekrite
  • Cleveland Clinic, Cleveland
Laj 40 ak plis · Tout sèks · Mizajou Aug 4, 2023 · NCT05919342

Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study

Ap rekriteFaz 4
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Jun 7, 2021 · NCT04191681

Etid Ensifizyans kadyak nan lòt vil

Lòt etid nan Cleveland

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.